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with an unbalanced Robertsonian translocation resulting in three copies of chromosome 13, demonstrating that isochromosome 13 was not detected by the
SNP-based cfDNA aneuploidy screening. Follow-up parental karyotypes were normal, conﬁrming that the translocation occurred de novo.
Case two presented to maternal fetal medicine care at 12 weeks gestational age due to an increased nuchal translucency of 5.54 mm. SNP-based cfDNA
aneuploidy screening was performed at 10 weeks, and the results returned low risk (<1 in 10,000) for trisomy 21, trisomy 13, trisomy 18, and monosomy X,
with a fetal fraction of 11.4%. Chorionic villus sampling was performed at 13 weeks. CVS karyotype results were abnormal: 46,XY,idic(18)(p11.3)[5]/46,XY
[15]. CVS microarray was also abnormal with a 4.9Mb deletion of 18p11.32p11.31, 3.9Mb duplication of 18p11.31p11.2, and 69Mb duplication of
18p11.2q23. This result is consistent with an isodicentric chromosome 18, likely to produce a phenotype similar to trisomy 18, and was not detected by the
SNP-based cfDNA aneuploidy screening. A follow-up ultrasound at 16 weeks identiﬁed a two-vessel cord, marginal cord insertion, umbilical cord cyst,
omphalocele, absent nasal bone, strawberry-shaped skull, and a unilateral choroid plexus cyst. The pregnancy ended in an uncomplicated dilation and
evacuation at 16 weeks gestational age. Parental follow-up testing was not pursued.
Conclusion: We present two cases of false-negative cfDNA aneuploidy screening results due to isochromosome 13 and isodicentric chromosome 18. It is
critical that providers and patients understand that cfDNA testing is a screening test where false negative results are rare but possible. While SNP-based cfDNA
is a highly effective cfDNA screening methodology, it has unique limitations for trisomies caused by isochromosomes and isodicentric chromosomes.
https://doi.org/10.1016/j.gim.2022.01.477
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Introduction: An association between long chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deﬁciency and acute fatty liver of pregnancy (AFLP) has been
demonstrated in many reports. The most common variant in clinical observations is the 1528G>C. Our goal was to evaluate the different fetal/neonatal
mitochondrial fatty acid oxidation (FAO) genetic variants associated with AFLP in the literature.
Methods: We conducted a search using the databases PubMed, Ovid MEDLINE, Cochrane, CINAHL Scopus and ClinicalTrials.gov from 1970-April 2021.
Relevant papers evaluating the possible relationship between AFLP and FAO were identiﬁed without any time, language, or study design limitations. Our
search terms were as follows: Trifunctional protein deﬁciency with myopathy and neuropathy or LCHAD or mitochondrial fatty acid oxidation or fatty acid
oxidation or newborn infant and AFLP or liver disease in pregnancy or hepatic disease or hepatic steatosis or liver steatosis or hepatic crisis and pregnancy or
maternal liver disease or labor or antepartum or postpartum. The study was registered in PROSPERO under the identiﬁcation tag CRD42021247166. The
reference sequence for all variants is NM_000182.5.
Results: Out of the 14 cases included in our review, 6 cases of AFLP (42.8%) were associated with homozygous 1528G>C variant in the fetus/neonate. Four
cases (28.5%) were compound heterozygous with the 1528G>C variant. The 4 compound heterozygous cases associated with AFLP were as follows:
1528G>C/1132C>T (premature stop codon variant), 1528G>C/D67 ter (Asp67ter variant in the alpha subunit exon 4), 1528G>C/T +2C (exon 12 splice site
transversion) and the last case was a compound heterozygous with a premature stop codon variant in exon 4 inherited from the father. One AFLP case was
associated with short-chain acyl-CoA dehydrogenase (SCAD) deﬁciency and another one with long-chain 3-ketoacyl CoA thiolase (LCKT) enzyme. Two cases
did not have any genetic testing but were suspected to have a FAO disorder based on acylcarnitine species and enzyme analysis.
Conclusion: Not all cases of AFLP reported in the literature are secondary to LCHAD deﬁciency or the 1528G>C variant. Other pathways such as SCAD and
LCKT may be involved. Further research is needed to evaluate the genetic etiologies of AFLP associated with FAO disorder.
https://doi.org/10.1016/j.gim.2022.01.478
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Introduction: Panorama is one of the most accurate and commonly used methods of cell free DNA noninvasive prenatal screening (NIPS). The results are
reported as either high risk for a speciﬁc aneuploidy, high risk due to fetal fraction, insufﬁcient fetal DNA, atypical, high risk, or no results. It is the only form of
NIPS that uses a single nucleotide polymorphism (SNP) method, representing genetic changes that are present in over 1% of the general population, to screen
for common fetal aneuploidies and microdeletion syndromes. We hypothesize that the SNP method could be leading to the increase in atypical results among
women in consanguineous relationships, common amongst Arab Americans, where there is high homogeneity of genetic material. The aim of this study is to
explore factors inﬂuencing atypical Panorama NIPS results and its association with abnormal fetal outcomes amongst Arab American women.
Methods: A retrospective cohort study was performed by looking at Panorama NIPS performed between September 2018 and January 2021 at a large urban
health system in Detroit, Michigan. The records were obtained from Natera, Inc, the clinical genetic testing company for Panorama. Singleton gestations who
underwent Panorama screening and had ‘atypical’ results were included. The outcome of interest was fetal anomalies or abnormal genetic outcomes.
Results: A total of 5,886 women underwent Panorama NIPS within the deﬁned time frame and 772 (13.1%) were identiﬁed as Arab Americans. Forty-nine
(0.79%) women had atypical results, of which 43 were singleton gestations. The mean age was 29.6 ± 5.3 years old. Nineteen women (44.2%) were White, 14
(32.6%) were Arab and 8 (18.6%) were Black. The percentage of Arab American women with atypical results (32.6%) was signiﬁcantly higher than the overall
percentage of Arab American women who ever underwent Panorama testing (13.0%) (p=0.00018). Eight women were in a known consanguineous relationship, all of whom identiﬁed as Arab Americans, hence making 57.1% of Arab women with atypical results. The outcomes for all 43 pregnancies showed
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normal fetal anatomy and no genetic abnormalities. In those who underwent further testing with amniocentesis (14.0%) or MaterniT21 (14.0%), the results were
all normal.
Conclusion: We identiﬁed a high percentage of Arab American women with atypical results compared to the baseline Arab American women ratio in the
population screened. More importantly, we identiﬁed a high rate of consanguinity amongst Arab women with atypical results and subsequent normal fetal
anatomy suggesting the possible inﬂuence of consanguinity on falsely elevated atypical results due to the SNP method used with Panorama testing. Such
knowledge might suggest that, for Arab American women, particularly consanguineous couples, Panorama testing may not be the most ideal method for NIPS.
This could help reduce unnecessary invasive testing and Maternal Fetal Medicine and genetics consultations.
https://doi.org/10.1016/j.gim.2022.01.479
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Background: Oculocerebrorenal syndrome (Lowe Syndrome), is a rare X-linked disorder affecting 1/500,000 males, that most frequently affects the eyes,
central nervous system, and kidneys. Phenotypic presentation includes congenital cataracts, developmental delay, intellectual disability, and Fanconi-type renal
dysfunction. Lowe Syndrome is caused by a variant in the OCRL gene. OCRL loss of function variants result in decreased enzyme levels and an accumulation
of the enzyme’s substrate, phosphatidylinositol (4,5) biphosphate (PiP2), and cytoskeletal defects. While individuals may live into the 3rd and 4th decade of
life, some will die in the ﬁrst few years from either renal failure or infection. We report a case of a family with an extensive history of congenital cataracts,
immune compromise, and neonatal death in male members with an ultimate diagnosis of Lowe Syndrome.
Case presentation: The patient was referred at 31 weeks 1 day gestation with a prenatal diagnosis of cerebral ventriculomegaly. The patient is a 29-year-old
G2P1 who conceived spontaneously and denied all exposures during the pregnancy. A three-generation pedigree was obtained. The family was from
Uzbekistan and consanguinity was denied. The patient reported that 4 of her 5 brothers died at very young ages. Two of her brothers died within the ﬁrst few
days of life, another brother died at 22 days of life, and the last brother died at 3 years of life following recovering from a surgery to remove his congenital
cataracts. All 4 brothers were said to have immune deﬁciency, which was reported to be their cause of death. Based on this pedigree, the family history was
concerning for X-linked severe combined immunodeﬁciency syndrome (SCIDS), however, the congenital cataract diagnosis presented as a confounder, as it is
not a typical ﬁnding in SCIDS. The patient further reported that her mother had two sisters, one of which had a son born with congenital cataracts and was of
severely short stature. This additional family history suggested that there might be an additional X-linked disorder causing cataracts and growth deﬁciency in
the family.
High-resolution ultrasound, fetal MRI, and fetal echocardiography were performed. No major structural defects of the heart were visualized. Ultrasound
demonstrated a male fetus with mild lateral cerebral ventriculomegaly, segmentation anomalies of the lower thoracic and lumbar spine, foreshortened long
bones, small umbilical cord cysts, and a left cataract. Neuro MRI reported possible germinolytic cysts bilaterally, with a normal corpus callosum and gyral
patterns appropriate for gestational age.
Given the presence of the congenital cataract, the patient was counseled on the possibility that this fetus was affected with the same condition as her brothers
and her maternal ﬁrst cousin. The patient opted to interrupt the pregnancy by KCl injection followed by induction of labor. A virtual autopsy was completed,
including CT and MRI examinations. Sagittal clefts of the thoracic and lumbar vertebrae were seen as was the left eye cataract of 0.3cm in size. Exome
sequencing (ES) was completed postmortem and reported a maternally inherited variant in OCRL, causative of Lowe Syndrome. There are reports in the
literature describing affected males with mild ventriculomegaly. As some individuals with Lowe Syndrome die within the ﬁrst years of life due to susceptibility
to infections and immunocompromise, it is possible that the brothers who died at young ages and did not have known cataracts, also had Lowe Syndrome.
Conclusion: This case highlights the critical importance of ascertaining a full and detailed family history with a multigeneration pedigree when evaluating
fetuses with congenital anomalies. Now that this condition has been identiﬁed for this family, other members can be tested, including the patient’s maternal
aunts and cousins. It also allows the family to pursue ART with preimplantation genetic diagnosis for future pregnancies. This case may also represent an
expansion of the phenotypic spectrum of this disease as Lowe syndrome has not been previously reported to present with clefting of the vertebrae of the lumbar
or thoracic spine.
https://doi.org/10.1016/j.gim.2022.01.480
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Background: Fetal akinesia deformation sequence (FADS), also known as Pena-Shokier Syndrome, is a clinical manifestation of arthrogryposis, abnormal
facial features, and pulmonary hypoplasia, and demonstrates a high degree of genetic heterogeneity. Variants within the genes that are involved in the
neuromuscular system are most frequently involved. One gene in particular, MUSK, is involved in the formation and maintenance of the neuromuscular
junction. Biallelic loss of function variants in this gene have been documented by 5 affected fetuses in a Swedish family and an affected fetus in a Dutch family.
We report a patient who had multiple pregnancies affected with a FADS phenotype who was found to have variants in the MUSK gene, causative of the
ultrasound ﬁndings.
Case presentation: The patient was evaluated at 20 weeks 4 days gestation for suspected fetal arthrogryposis. She reported a previous pregnancy that was
similarly affected with arthrogryposis, rocker bottom feet, non-immune hydrops fetalis (NIHF), and polyhydramnios that ended in intrauterine fetal demise at

